SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-235597
Filing Date
2018-08-02
Accepted
2018-08-02 07:17:04
Documents
2
Period of Report
2018-08-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d599885d8k.htm 8-K 16817
2 EX-99.1 d599885dex991.htm EX-99.1 66946
  Complete submission text file 0001193125-18-235597.txt   84991
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36274 | Film No.: 18986647
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences